Habitus Associates Co., LTD
18.9.2023 00:34:28 CEST | ACCESS Newswire | Press release
SEOUL, SOUTH KOREA / ACCESSWIRE / September 17, 2023 / Habitus Associates Co., LTD., the entity behind the online art platform 'Artue' and under the leadership of Bo Young SONG, has secured a seed investment of 4 billion won. This investment round was led by SoftBank Ventures Asia with several angel investors also taking part.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Artue, powered by Habitus Associates Co., LTD, is pioneering the art industry's digital transformation. The platform is revolutionizing the traditionally offline, high-barrier art brokerage, providing emerging artists with market entry opportunities and reducing purchasing barriers for collectors.
A notable feature of Artue is its digital twin technology, enabling a virtual experience that mirrors physical art spaces. With the integration of online transactional capabilities, Artue is also enhancing its digital Catalogue Raisonné service and introducing resale functionalities.
The team at Habitus Associates Co., LTD. comprises industry veterans from influential corporations like Naver, Kakao, Credit-Suisse, LG, Hyundai Motor Group, Kukje Gallery, and Korea Arts Management Service. The advisory board includes Eugene Whang, with two decades at Apple; Alan Lau, previously of Tencent and now with Animoca Brands; Changwook Kim of Naver; and Federico Tan, a communications specialist with clients including Sacai and Takashi Murakami.
With the new funds, the company intends to further develop and hone Artue's offerings, boost its technical capabilities, and expand its reach. Strategic talent acquisition and international artist promotion are also on the agenda, along with securing additional intellectual properties to diversify Artue's portfolio.
In 2022, the global art market was valued at an impressive 80 trillion won, with projections indicating continued growth driven by an increase in affluent individuals and the expanding digital landscape. Remarkably, South Korea's art market achieved over 1 trillion won in sales during the challenging pandemic year. Estimates for 2022 show potential growth to 1.377 trillion won. With Seoul witnessing a surge in global galleries and auction houses, South Korea is positioning itself as a significant player in the art market alongside giants like the US, UK, China, and Japan.
Bo Young SONG, co-founder of Habitus Associates Co., LTD., has served as a member of the Selection Committee member of Art Basel Hong Kong for a decade and as the first Asian partner and the regional CEO of renowned European art publisher Cahiers d'Art. She stated, "Artue is our response to the digital era. Beyond traditional art experiences, our platform aims to expedite and enhance the journey of gallerists, artists, and collectors."
JP Lee, CEO of SoftBank Ventures Asia, added, "Habitus Associates Co., LTD. seamlessly integrates art with IT, revolutionizing the traditional art market. We will actively support the continued growth of Artue and, furthermore, the digital transition of the art market."
Contact Information
Ines On Sim
Communications Manager
ines@artue.io
+82-10-6298-5999
Related Files
About SoftBank Ventures Asia & Habitus Associates.docx
SOURCE: Habitus Associates Co., LTD
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/784622/softbank-ventures-asia-invests-in-habitus-associates-co-ltd-leading-the-digital-transition-of-the-art-industry
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom